Literature DB >> 20231113

Serum inhibin A concentration in women with polycystic ovarian syndrome and the correlation to ethnicity, androgens and insulin resistance.

Shimon Segal1, Malvina Elmadjian, Takeko Takeshige, Steven Karp, Ray Mercado, Benjamin Rivnay.   

Abstract

A prospective case-series in an academic hospital clinic was performed to determine whether there is a relationship between polycystic ovarian syndrome (PCOS) and ethnicity. Also, serum inhibin A concentrations were compared between PCOS and normal-ovulatory women. The possibility of a correlation between inhibin A, androgens and insulin resistance in PCOS women was evaluated. Serum inhibin A concentrations were measured in anovulatory PCOS patients (n=32) and in control women of reproductive age (n=16). Statistical analysis was performed using the Mann-Whitney U-test. Serum concentrations of inhibin A, follicle-stimulating hormone, LH, prolactin, thyroid-stimulating hormone, fasting glucose, insulin, testosterone, 17-hydroxyprogesterone (17-OHP) and dehydroepiandrosterone sulphate (DHEAS) were measured. Inhibin A concentrations were significantly lower (4.5+/-4.8 pg/ml) when compared with the control group (13.2+/-14.4 pg/ml; P=0.003) and were not significantly different between Hispanic and Caucasian women diagnosed with PCOS. There was no correlation between inhibin A concentrations and insulin, testosterone, free testosterone, 17-OHP, or DHEAS concentrations. In PCOS women, inhibin A concentrations are similar between Hispanic and Caucasian women; however, women with PCOS, regardless of ethnicity, have a lower inhibin A concentration compared with normal-ovulatory women. No correlation was observed between inhibin A androgens and insulin resistance in women diagnosed with PCOS. Copyright (c) 2010 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20231113     DOI: 10.1016/j.rbmo.2010.02.006

Source DB:  PubMed          Journal:  Reprod Biomed Online        ISSN: 1472-6483            Impact factor:   3.828


  4 in total

1.  Should we change our mind about second trimester biochemical aneuploidy screening markers of patients with polycystic ovary syndrome?

Authors:  V Korkmaz; Z Kurdoglu; Y Ergun
Journal:  J Endocrinol Invest       Date:  2015-06-16       Impact factor: 4.256

2.  Assessing and treating insulin resistance in women with polycystic ovarian syndrome.

Authors:  Michael L Traub
Journal:  World J Diabetes       Date:  2011-03-15

3.  Inhibin secretion in women with the polycystic ovary syndrome before and after treatment with progesterone.

Authors:  Konstantinos Dafopoulos; Christos Venetis; Christina I Messini; Spyros Pournaras; George Anifandis; Antonios Garas; Ioannis E Messinis
Journal:  Reprod Biol Endocrinol       Date:  2011-04-29       Impact factor: 5.211

4.  Anti-Müllerian Hormone and Inhibin-A, but not Inhibin-B or Insulin-Like Peptide-3, may be Used as Surrogates in the Diagnosis of Polycystic Ovary Syndrome in Adolescents: Preliminary Results.

Authors:  Aylin Yetim; Çağcıl Yetim; Firdevs Baş; Oğuz Bülent Erol; Gülnaz Çığ; Ahmet Uçar; Feyza Darendeliler
Journal:  J Clin Res Pediatr Endocrinol       Date:  2016-04-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.